200 related articles for article (PubMed ID: 19321341)
1. Discovery of novel dihydro-9,10-ethano-anthracene carboxamides as glucocorticoid receptor modulators.
Yang BV; Vaccaro W; Doweyko AM; Doweyko LM; Huynh T; Tortolani D; Nadler SG; McKay L; Somerville J; Holloway DA; Habte S; Weinstein DS; Barrish JC
Bioorg Med Chem Lett; 2009 Apr; 19(8):2139-43. PubMed ID: 19321341
[TBL] [Abstract][Full Text] [Related]
2. Octahydrophenanthrene-2,7-diol analogues as dissociated glucocorticoid receptor agonists: discovery and lead exploration.
Robinson RP; Buckbinder L; Haugeto AI; McNiff PA; Millham ML; Reese MR; Schaefer JF; Abramov YA; Bordner J; Chantigny YA; Kleinman EF; Laird ER; Morgan BP; Murray JC; Salter ED; Wessel MD; Yocum SA
J Med Chem; 2009 Mar; 52(6):1731-43. PubMed ID: 19239259
[TBL] [Abstract][Full Text] [Related]
3. Novel N-arylpyrazolo[3,2-c]-based ligands for the glucocorticoid receptor: receptor binding and in vivo activity.
Ali A; Thompson CF; Balkovec JM; Graham DW; Hammond ML; Quraishi N; Tata JR; Einstein M; Ge L; Harris G; Kelly TM; Mazur P; Pandit S; Santoro J; Sitlani A; Wang C; Williamson J; Miller DK; Thompson CM; Zaller DM; Forrest MJ; Carballo-Jane E; Luell S
J Med Chem; 2004 May; 47(10):2441-52. PubMed ID: 15115388
[TBL] [Abstract][Full Text] [Related]
4. Azaxanthene based selective glucocorticoid receptor modulators: design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791826).
Weinstein DS; Gong H; Doweyko AM; Cunningham M; Habte S; Wang JH; Holloway DA; Burke C; Gao L; Guarino V; Carman J; Somerville JE; Shuster D; Salter-Cid L; Dodd JH; Nadler SG; Barrish JC
J Med Chem; 2011 Oct; 54(20):7318-33. PubMed ID: 21899328
[TBL] [Abstract][Full Text] [Related]
5. Discovery and SAR study of novel dihydroquinoline-containing glucocorticoid receptor agonists.
Takahashi H; Bekkali Y; Capolino AJ; Gilmore T; Goldrick SE; Kaplita PV; Liu L; Nelson RM; Terenzio D; Wang J; Zuvela-Jelaska L; Proudfoot J; Nabozny G; Thomson D
Bioorg Med Chem Lett; 2007 Sep; 17(18):5091-5. PubMed ID: 17681466
[TBL] [Abstract][Full Text] [Related]
6. Dissociated nonsteroidal glucocorticoid receptor modulators; discovery of the agonist trigger in a tetrahydronaphthalene-benzoxazine series.
Barker M; Clackers M; Copley R; Demaine DA; Humphreys D; Inglis GG; Johnston MJ; Jones HT; Haase MV; House D; Loiseau R; Nisbet L; Pacquet F; Skone PA; Shanahan SE; Tape D; Vinader VM; Washington M; Uings I; Upton R; McLay IM; Macdonald SJ
J Med Chem; 2006 Jul; 49(14):4216-31. PubMed ID: 16821781
[TBL] [Abstract][Full Text] [Related]
7. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
[TBL] [Abstract][Full Text] [Related]
8. Discovery and optimization of novel, non-steroidal glucocorticoid receptor modulators.
Ray NC; Clark RD; Clark DE; Williams K; Hickin HG; Crackett PH; Dyke HJ; Lockey PM; Wong M; Devos R; White A; Belanoff JK
Bioorg Med Chem Lett; 2007 Sep; 17(17):4901-5. PubMed ID: 17587578
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of in vitro transcriptional repression and activation profiles of selective glucocorticoid modulators.
Elmore SW; Pratt JK; Coghlan MJ; Mao Y; Green BE; Anderson DD; Stashko MA; Lin CW; Falls D; Nakane M; Miller L; Tyree CM; Miner JN; Lane B
Bioorg Med Chem Lett; 2004 Apr; 14(7):1721-7. PubMed ID: 15026058
[TBL] [Abstract][Full Text] [Related]
10. Non-steroidal dissociated glucocorticoid agonists: indoles as A-ring mimetics and function-regulating pharmacophores.
Betageri R; Gilmore T; Kuzmich D; Kirrane TM; Bentzien J; Wiedenmayer D; Bekkali Y; Regan J; Berry A; Latli B; Kukulka AJ; Fadra TN; Nelson RM; Goldrick S; Zuvela-Jelaska L; Souza D; Pelletier J; Dinallo R; Panzenbeck M; Torcellini C; Lee H; Pack E; Harcken C; Nabozny G; Thomson DS
Bioorg Med Chem Lett; 2011 Nov; 21(22):6842-51. PubMed ID: 21963986
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophore.
Razavi H; Riether D; Harcken C; Bentzien J; Dinallo RM; Souza D; Nelson RM; Kukulka A; Fadra-Khan TN; Pack EJ; Zuvela-Jelaska L; Pelletier J; Panzenbeck M; Torcellini CA; Proudfoot JR; Nabozny GH; Thomson DS
Bioorg Med Chem Lett; 2014 Apr; 24(8):1934-40. PubMed ID: 24656565
[TBL] [Abstract][Full Text] [Related]
12. Dimethyl-diphenyl-propanamide derivatives as nonsteroidal dissociated glucocorticoid receptor agonists.
Yang BV; Weinstein DS; Doweyko LM; Gong H; Vaccaro W; Huynh T; Xiao HY; Doweyko AM; McKay L; Holloway DA; Somerville JE; Habte S; Cunningham M; McMahon M; Townsend R; Shuster D; Dodd JH; Nadler SG; Barrish JC
J Med Chem; 2010 Dec; 53(23):8241-51. PubMed ID: 21073190
[TBL] [Abstract][Full Text] [Related]
13. The 11-ketosteroid 11-ketodexamethasone is a glucocorticoid receptor agonist.
Rebuffat AG; Tam S; Nawrocki AR; Baker ME; Frey BM; Frey FJ; Odermatt A
Mol Cell Endocrinol; 2004 Feb; 214(1-2):27-37. PubMed ID: 15062542
[TBL] [Abstract][Full Text] [Related]
14. Discovery of potent and selective nonsteroidal indazolyl amide glucocorticoid receptor agonists.
Sheppeck JE; Gilmore JL; Xiao HY; Dhar TG; Nirschl D; Doweyko AM; Sack JS; Corbett MJ; Malley MF; Gougoutas JZ; Mckay L; Cunningham MD; Habte SF; Dodd JH; Nadler SG; Somerville JE; Barrish JC
Bioorg Med Chem Lett; 2013 Oct; 23(19):5442-7. PubMed ID: 23953070
[TBL] [Abstract][Full Text] [Related]
15. Novel synthesis of the hexahydroimidazo[1,5b]isoquinoline scaffold: application to the synthesis of glucocorticoid receptor modulators.
Xiao HY; Wu DR; Malley MF; Gougoutas JZ; Habte SF; Cunningham MD; Somerville JE; Dodd JH; Barrish JC; Nadler SG; Dhar TG
J Med Chem; 2010 Feb; 53(3):1270-80. PubMed ID: 20047280
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal selective glucocorticoid modulators: the effect of C-10 substitution on receptor selectivity and functional potency of 5-allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines.
Kym PR; Kort ME; Coghlan MJ; Moore JL; Tang R; Ratajczyk JD; Larson DP; Elmore SW; Pratt JK; Stashko MA; Falls HD; Lin CW; Nakane M; Miller L; Tyree CM; Miner JN; Jacobson PB; Wilcox DM; Nguyen P; Lane BC
J Med Chem; 2003 Mar; 46(6):1016-30. PubMed ID: 12620078
[TBL] [Abstract][Full Text] [Related]
17. Identification of dissociated non-steroidal glucocorticoid receptor agonists.
Kuzmich D; Kirrane T; Proudfoot J; Bekkali Y; Zindell R; Beck L; Nelson R; Shih CK; Kukulka AJ; Paw Z; Reilly P; Deleon R; Cardozo M; Nabozny G; Thomson D
Bioorg Med Chem Lett; 2007 Sep; 17(18):5025-31. PubMed ID: 17692519
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.
Schäcke H; Schottelius A; Döcke WD; Strehlke P; Jaroch S; Schmees N; Rehwinkel H; Hennekes H; Asadullah K
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):227-32. PubMed ID: 14694204
[TBL] [Abstract][Full Text] [Related]
19. Steroidal C-21 heteroaryl thioethers (Part 2): discovery of orally bioavailable selective glucocorticoid receptor modulators (dissociated steroids).
Biju P; McCormick K; Aslanian R; Berlin M; Solomon D; Wang H; Lee YJ; Bitar R; Prelusky D; McLeod R; Jia Y; Fernandez X; Eckel S; House A; Lieber G; Jimenez J; Kelly G; Chapman R; Phillips J; Anthes J
Bioorg Med Chem Lett; 2012 Jan; 22(2):1086-90. PubMed ID: 22197391
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydroquinoline glucocorticoid receptor agonists: discovery of a 3-hydroxyl for improving receptor selectivity.
Roach SL; Higuchi RI; Hudson AR; Adams ME; Syka PM; Mais DE; Miner JN; Marschke KB; Zhi L
Bioorg Med Chem Lett; 2011 Jan; 21(1):168-71. PubMed ID: 21115247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
